Skip to main content
. 2016 Mar 2;7(11):11945–11958. doi: 10.18632/oncotarget.7858

Figure 6. In vivo anti-TNF-α treatment and endothelial senescence-associated miR expression levels in psoriatic patients.

Figure 6

MiR-146a-5p A. and miR-126-3p B. expression in CACs from 13 psoriasis patients before and after 3 month anti-TNF-α monotherapy with adalimumab. P from Student's t test for paired samples.

HHS Vulnerability Disclosure